Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0063
Full Text
Open PDFAbstract
Available in full text
Date
October 22, 2015
Authors
Publisher
American Association for Cancer Research (AACR)